Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
Open-market buys, last 90 days
$35,023,032
in 1 filing
Open-market sales, last 90 days
$7,011,938
in 3 filings, $6.7M under 10b5-1 plans

Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. BAKER BROS. ADVISORS LP +$35.0M Director 1 filing
  2. Sibold William John −$6.2M President and CEO sold 6% of stake
  3. Kelley Shannon T −$773K General Counsel sold 14% of stake
Date Insider Transaction Shares Price Value Owned after
2018-06-11 CRAVES FRED B Director Sale −5,908 $287.46 $1.7M 113,472
2018-06-11 Schneebaum Marc R Chief Financial Officer Option exercise +5,223 $99.75 $521K 49,033
2018-06-11 Schneebaum Marc R Chief Financial Officer Option exercise +2,734 $61.60 $168K 51,767
2018-06-11 Schneebaum Marc R Chief Financial Officer Sale −10,099 $287.46 $2.9M 41,668
2018-06-11 Schneebaum Marc R Chief Financial Officer Option exercise · Stock Option −5,223 1,205
2018-06-11 Schneebaum Marc R Chief Financial Officer Option exercise · Stock Option −2,734 1,640
2018-06-11 CRAVES FRED B Director Sale −274,092 $287.46 $78.8M 5,264,382
2018-06-11 CRAVES FRED B Director Sale +5,908 $287.46 $1.7M 113,472
2018-06-11 FRIEDMAN PAUL A Chief Executive Officer Sale −73,526 $287.46 $21.1M 655,540
2018-06-11 Taub Rebecca Chief Medical Officer, EVP R&D Sale +73,526 $287.46 $21.1M 655,540
2018-06-11 BAY CITY CAPITAL LLC Director Sale −274,092 $287.46 $78.8M 5,264,382
2018-06-11 BAY CITY CAPITAL LLC Director Sale −5,908 $287.46 $1.7M 113,472
2018-03-01 Schneebaum Marc R Chief Financial Officer Grant or award · Stock Option (Right to Buy) +28,000 28,000
2018-03-01 Taub Rebecca Chief Medical Officer, EVP R&D Grant or award · Stock Option (Right to Buy) +38,000 38,000
2018-03-01 FRIEDMAN PAUL A Chief Executive Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2017-08-23 Levy Richard S Director Purchase +100 $16.08 $2K 7,200
2017-08-23 Levy Richard S Director Purchase +100 $16.11 $2K 7,300
2017-08-23 Levy Richard S Director Purchase +1,793 $16.12 $29K 9,093
2017-08-23 Levy Richard S Director Purchase +7 $16.25 $114 9,100
2017-08-22 Levy Richard S Director Purchase +90 $15.99 $1K 3,640

Page 56 of 82 · 1,629 trades